Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 468,376 | 415,307 | -53,069 | $45.55M | $77.78M | 8.32% | +$32.23M |
| ABIVAX Société Anonyme(ABVX) | 465,869 | 489,889 | +24,020 | $51.87M | $65.28M | 6.98% | +$13.41M |
| Axsome Therapeutics, Inc.(AXSM) | 188,772 | 218,415 | +29,643 | $31.91M | $53.46M | 5.72% | +$21.56M |
| ENLIVEN THERAPEUTICS INC | 623,839 | 954,360 | +330,521 | $24.45M | $48.43M | 5.18% | +$23.98M |
| BridgeBio Pharma, Inc.(BBIO) | 695,718 | 633,364 | -62,354 | $51.66M | $47.17M | 5.05% | -$4.49M |
| Roivant Sciences Ltd.(ROIV) | 1,190,118 | 1,331,066 | +140,948 | $32.97M | $47.11M | 5.04% | +$14.14M |
| United Therapeutics Corporation(UTHR) | 104,726 | 84,932 | -19,794 | $62.10M | $46.02M | 4.92% | -$16.08M |
| Cytokinetics, Incorporated(CYTK) | 283,700 | 527,412 | +243,712 | $18.70M | $44.93M | 4.81% | +$26.23M |
| Xenon Pharmaceuticals Inc.(XENE) | 786,844 | 600,200 | -186,644 | $45.75M | $36.23M | 3.88% | -$9.53M |
| Celcuity Inc.(CELC) | 210,578 | 329,101 | +118,523 | $24.04M | $34.43M | 3.68% | +$10.40M |
| Viridian Therapeutics, Inc.(VRDN) | 911,337 | 1,670,000 | +758,663 | $17.83M | $30.68M | 3.28% | +$12.85M |
| Insmed Incorporated(INSM) | 248,475 | 263,851 | +15,376 | $40.63M | $28.13M | 3.01% | -$12.50M |
| uniQure N.V.(QURE) | 615,489 | 608,925 | -6,564 | $10.06M | $28.05M | 3.00% | +$17.98M |
| Ascendis Pharma A/S(ASND) | 0 | 104,877 | +104,877 | $0 | $27.97M | 2.99% | +$27.97M |
| Praxis Precision Medicines, Inc.(PRAX) | 42,441 | 83,528 | +41,087 | $13.67M | $27.96M | 2.99% | +$14.29M |
| Dianthus Therapeutics, Inc.(DNTH) | 220,921 | 285,771 | +64,850 | $18.54M | $27.86M | 2.98% | +$9.32M |
| Vaxcyte, Inc.(PCVX) | 0 | 443,836 | +443,836 | $0 | $25.80M | 2.76% | +$25.80M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 400,464 | 218,051 | -182,413 | $36.99M | $25.53M | 2.73% | -$11.47M |
| Palvella Therapeutics, Inc.(PVLA) | 148,093 | 156,450 | +8,357 | $18.46M | $23.91M | 2.56% | +$5.45M |
| Cogent Biosciences, Inc.(COGT) | 947,339 | 602,281 | -345,058 | $36.46M | $23.31M | 2.49% | -$13.15M |
| Erasca, Inc.(ERAS) | 867,639 | 1,221,721 | +354,082 | $14.04M | $22.38M | 2.39% | +$8.34M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,017,284 | 2,017,284 | 0 | $25.56M | $21.85M | 2.34% | -$3.71M |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 558,336 | 582,497 | +24,161 | $17.87M | $19.74M | 2.11% | +$1.87M |
| APOGEE THERAPEUTICS INC | 513,770 | 138,822 | -374,948 | $43.24M | $18.43M | 1.97% | -$24.82M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 154,018 | +154,018 | $0 | $17.10M | 1.83% | +$17.10M |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 164,783 | +164,783 | $0 | $15.61M | 1.67% | +$15.61M |
| Scholar Rock Holding Corporation(SRRK) | 446,390 | 271,227 | -175,163 | $21.94M | $14.92M | 1.60% | -$7.03M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 155,343 | +155,343 | $0 | $14.78M | 1.58% | +$14.78M |
| Kymera Therapeutics, Inc.(KYMR) | 254,672 | 102,533 | -152,139 | $21.21M | $11.76M | 1.26% | -$9.45M |
| SIONNA THERAPEUTICS INC | 0 | 110,493 | +110,493 | $0 | $4.86M | 0.52% | +$4.86M |
| NUVALENT INC | 370,344 | 26,298 | -344,046 | $37.94M | $3.25M | 0.35% | -$34.69M |
| Ascendis Pharma A/S(ASND) | 76,300 | 0 | -76,300 | $17.45M | $0 | — | -$17.45M |
| FULCRUM THERAPEUTICS INC | 2,256,109 | 0 | -2,256,109 | $17.30M | $0 | — | -$17.30M |
| IDEAYA Biosciences, Inc.(IDYA) | 873,838 | 0 | -873,838 | $29.12M | $0 | — | -$29.12M |
| MoonLake Immunotherapeutics(MLTX) | 315,563 | 0 | -315,563 | $5.88M | $0 | — | -$5.88M |
| Natera, Inc.(NTRA) | 81,077 | 0 | -81,077 | $16.21M | $0 | — | -$16.21M |
| OLEMA PHARMACEUTICALS INC | 768,662 | 0 | -768,662 | $11.46M | $0 | — | -$11.46M |
| TERNS PHARMACEUTICALS INC | 326,694 | 0 | -326,694 | $17.22M | $0 | — | -$17.22M |
| Vera Therapeutics, Inc.(VERA) | 422,023 | 0 | -422,023 | $16.98M | $0 | — | -$16.98M |